Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90
Published November 20, 2024 · Recall initiated: October 23, 2024
Summary
FDA records drug Class II recall D-0044-2025, published November 20, 2024 and initiated October 23, 2024. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot# NB240873, Exp 03/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cipla USA, Inc.
- Distributor
- USA nationwide.
- Lot
- Lot# NB240873, Exp 03/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-DoseOctober 14, 2026
- FDACinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDACinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDACinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDALanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDCNovember 20, 2024
- FDAHydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet PharmaceuticalsNovember 20, 2024
Questions about this recall
Was Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90 recalled?
Yes. FDA published recall D-0044-2025 on November 20, 2024. Reported hazard: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter